CTOs on the Move

Reimage

www.reimage.com

 
Reimage is a New York, NY-based company in the Software and Internet sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

G2

G2 is the world`s largest and most trusted marketplace to discover, review, and manage B2B software. More than 60 million people every year use G2 to make smarter software decisions based on authentic peer reviews, and thousands of companies of all sizes partner with G2 to build their reputation, manage their software spend, and grow their business. All of the FORTUNE 500 use G2, including Salesforce, Zoom, and Adobe.

Nuxeo

Nuxeo is the leader in Open Source ECM (Enterprise Content Management) with its Nuxeo Enterprise Platform (formerly named Nuxeo CPS). Nuxeo Enterprise Platform helps companies improve business processes efficiency, collaboration and adherence to

Stynt

Looking for a new healthcare job in the dental or medical industry? Use Stynt to search, apply and get hired for temporary and permanent jobs posted by thousands of dental and medical practices nationwide.

Crunchbase

Crunchbase is a platform that provides company insights from early stage startups to the Fortune 1000. It is the destination for learning about companies, discovering investments and industry trends, and finding news about hundreds of thousands of publ...

Immunome

Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.